meglumine antimoniate has been researched along with Adverse Drug Event in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carvalho, AG; Carvalho, CDP; Carvalho, RDP; Dias, JVL; Luz, JGG; Pires, HHR | 1 |
| Alves, FP; Amaral, TA; Costa, CHN; Costa, DL; de Almeida, RP; de Carvalho, AL; de Carvalho, SFG; de Melo, EV; Leite, RD; Lima, SS; Rabello, A; Rode, J; Romero, GAS; Sousa, AQ | 1 |
| Marques, MEA; Marques, SA; Merlotto, MR; Ramos, PM | 1 |
| Azeredo-Coutinho, RB; Baptista, C; Conceição-Silva, F; de Almeida Marzochi, MC; de Camargo Ferreira E Vasconcellos, E; de Fátima Madeira, M; de Matos Salgueiro, M; de Oliveira Schubach, A; de Souza Coutinho, R; Fernandes Pimentel, MI; Pereira Quintella, L; Roberto Mortari, S; Rosandiski Lyra, M; Soares Moreira, J; Valete-Rosalino, CM | 1 |
1 trial(s) available for meglumine antimoniate and Adverse Drug Event
| Article | Year |
|---|---|
Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trial.
Topics: Adolescent; Adult; Amphotericin B; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome; Young Adult | 2017 |
3 other study(ies) available for meglumine antimoniate and Adverse Drug Event
| Article | Year |
|---|---|
"It's not all about the disease": do treatment and socioeconomic status affect perceived impact and satisfaction of patients treated for cutaneous leishmaniasis?
Topics: Antiprotozoal Agents; Cross-Sectional Studies; Drug-Related Side Effects and Adverse Reactions; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Patient Satisfaction; Social Class | 2023 |
American tegumentary leishmaniasis: severe side effects of pentavalent antimonial in a patient with chronic renal failure.
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Brazil; Drug-Related Side Effects and Adverse Reactions; Humans; Leishmaniasis, Cutaneous; Male; Meglumine Antimoniate; Renal Dialysis; Renal Insufficiency, Chronic | 2019 |
American tegumentary leishmaniasis in older adults: 44 cases treated with an intermittent low-dose antimonial schedule in Rio de Janeiro, Brazil.
Topics: Age Factors; Aged; Aged, 80 and over; Antiprotozoal Agents; Brazil; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2010 |